Dr Flavia Pichiorri is a Los Angeles–based cancer researcher and scientific writer whose work focuses on clinical and translational research in multiple myeloma and other blood cancers. Her career has been shaped by a steady commitment to turning complex scientific ideas into real therapies that can help patients.

She was born in Rome, Italy, and grew up in a family rooted in engineering, statistics, and organisational science. This early exposure to structured thinking influenced her approach to problem-solving. At the same time, she spent much of her childhood outdoors, riding horses along the historic Appia Antica. Years of show jumping taught her discipline and resilience, qualities that would later define her work in science.

She studied molecular biology and biochemistry at the University of Rome “Tor Vergata”, where she graduated with top honours. Her early research explored enzyme function and later shifted towards cancer biology, particularly multiple myeloma. After moving to the United States, she continued her research at Thomas Jefferson University and The Ohio State University, where she studied tumour biology and epigenetic mechanisms in cancer.

Over time, her work expanded into translational research, focusing on therapies targeting CD38 and CD84, as well as radiation-based approaches. She has contributed to early-phase clinical studies and the development of new treatment strategies.

Today, her work continues to connect laboratory research with clinical application. She remains focused on asking better questions, staying curious, and pushing scientific ideas forward one step at a time.